Evidence map›Paper›PMID 29892299›Full record

ArticleFrontiers in immunology2018

IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells.

Alex M Abel, Aradhana A Tiwari, Zachary J Gerbec, Jason R Siebert, Chao Yang, Nathan J Schloemer, Kate J Dixon, Monica S Thakar, Subramaniam Malarkannan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. A PI3K/AKT Scaffolding Protein, IQ Motif-Containing GTPase Associating Protein 1 (IQGAP1), Promotes Head and Neck Carcinogenesis.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  10. Cancer immunology research · 2019
    Article
  11. Immunometabolism and natural killer cell responses.Nature reviews. Immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alex M AbelDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.
Aradhana A TiwariLaboratory of Molecular Immunology and Immunotherapy, Blood Research Institute, Milwaukee, WI, United States.
Zachary J GerbecDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.
Jason R SiebertDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.
Chao YangDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.
Nathan J SchloemerLaboratory of Molecular Immunology and Immunotherapy, Blood Research Institute, Milwaukee, WI, United States.
Kate J DixonDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.
Monica S ThakarLaboratory of Molecular Immunology and Immunotherapy, Blood Research Institute, Milwaukee, WI, United States.
Subramaniam MalarkannanDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, United States.
Versiti Blood Center of Wisconsin · USMedical College of Wisconsin · US

Funding

Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
RESEARCH TRAINING IN TRANSFUSION SCIENCET32HL007209 · NHLBI · VERSITI WISCONSIN, INC. · PI WHITE, II, GILBERT C. · 1985 to 2019
$2.9M
Molecular signature of inflammationR01CA179363 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI MALARKANNAN, SUBRAMANIAM · 2014 to 2018
$1.6M
Molecular mechanisms of signaling co-ordination in innate lymphocytesR01AI102893 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI MALARKANNAN, SUBRAMANIAM · 2013 to 2016
$1.5M
NCI NIH HHS R01 CA179363NHLBI NIH HHS T32 HL007209NIAID NIH HHS R01 AI102893NIGMS NIH HHS T32 GM080202
6 · The paper itself

Abstract

Natural killer (NK) cells are innate lymphocytes that play essential roles in mediating antitumor immunity. NK cells respond to various inflammatory stimuli including cytokines and stress-induced cellular ligands which activate germline-encoded activation receptors (NKRs), such as NKG2D. The signaling molecules activated downstream of NKRs are well defined; however, the mechanisms that regulate these pathways are not fully understood. IQ domain-containing GTPase-activating protein 1 (IQGAP1) is a ubiquitously expressed scaffold protein. It regulates diverse cellular signaling programs in various physiological contexts, including immune cell activation and function. Therefore, we sought to investigate the role of IQGAP1 in NK cells. Development and maturation of NK cells from mice lacking IQGAP1 (

Indexed as

AnimalsCytokinesCytoskeletonKiller Cells, NaturalMechanistic Target of Rapamycin Complex 1MiceMice, KnockoutNK Cell Lectin-Like Receptor Subfamily KProtein Biosynthesisras GTPase-Activating ProteinsCytokinesIQ motif containing GTPase activating protein 1Klrk1 protein, mouseMechanistic Target of Rapamycin Complex 1NK Cell Lectin-Like Receptor Subfamily Kras GTPase-Activating ProteinscytoskeletonIFN-γIQ domain-containing GTPase-activating protein 1mechanistic target of rapamycinnatural killer cellsNKG2Dribosomal protein S6translation

Identifiers

PMID29892299
PMCPMC5985319
OpenAlexW2802323367

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.